Plasma malondialdehyde may not predict mortality in patient with chronic kidney disease;Le malondialdéhyde est-il un facteur prédictif de mortalité chez les patients ayant une maladie rénale chronique ?

Nephrologie et Therapeutique

Volumn 7, Issue 4, 2011, Pages 219-224

  Terrier Lenglet, Aurélie ^a,b   Nollet, Aude ^a   Liabeuf, Sophie ^a,b   Barreto, Daniela V ^a,b   Brazier, Michel ^b   Lemke, Horst Dieter ^c   Vanholder, Raymond ^d   Choukroun, Gabriel ^a,b   Massy, Ziad A ^a,b  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^c eXcorLab GmbH   (Germany)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Chronic kidney disease; Malondialdehyde; Oxidative stress

Indexed keywords

MALONALDEHYDE;

AORTA CALCIFICATION; ARTICLE; BLOOD LEVEL; CALCIFICATION; CHRONIC KIDNEY DISEASE; DISEASE SEVERITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MORTALITY; PULSE WAVE; SCORING SYSTEM; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE PROGRESSION; FEMALE; FRANCE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

EID: 79960156714     PISSN: 17697255     EISSN: 18729177     Source Type: Journal    
DOI: 10.1016/j.nephro.2010.12.009     Document Type: Article

References (24)

1. R.N. Foley, P.S. Parfrey, and M.J. Sarnak Epidemiology of cardiovascular disease in chronic renal disease J Am Soc Nephrol 9 1998 S16 S23
2. A.S. Levey, J.A. Beto, B.E. Coronado, G. Eknoyan, R.N. Foley, and B.L. Kasiske Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease Am J Kidney Dis 32 5 1998 853 906 (Pubitemid 28516321)
3. Z.A. Massy, P. Stenvinkel, and T.B. Drueke The role of oxidative stress in chronic kidney disease Semin Dial 22 4 2009 405 408
4. H. Sies Oxidative stress: oxidants and antioxidants Exp Physiol 82 2 1997 291 295 (Pubitemid 27182306)
5. Kita T, Kume N, Minami M, Hayashida K, Murayama T, Sano H, et al. Role of oxidized LDL in atherosclerosis. Ann N Y Acad Sci 2001;947:199-206. (Pubitemid 34059914)
6. G.A. Kaysen Inflammation and oxidative stress in end-stage renal disease Adv Nephrol Necker Hosp 30 2000 201 214
7. J. Mimić-Oka, T. Simić, L. Djukanović, Z. Reljić, and Z. Davicević Alteration in plasma antioxidant capacity in various degrees of chronic renal failure Clin Nephrol 51 4 1999 233 241 (Pubitemid 29196887)
8. T.B. Drüeke, T. Nguyen Khoa, Z.A. Massy, V. Witko-Sarsat, B. Lacour, and B. Descamps-Latscha Role of oxidized low-density lipoprotein in the atherosclerosis of uremia Kidney Int Suppl 78 2001 S114 S119
9. J. Steghens, F. Combarnous, W. Arkouche, F. Flourie, and A. Hadj-Aissa Influence de l'hémodialyse sur les concentrations de malonedialdé hyde total et libre, mesurées par une nouvelle technique HPLC spécifique Néphrologie & Thérapeutique 1 2 2005 121 125 (Pubitemid 41097634)
10. J.L. Paul, N.D. Sall, T. Soni, J.L. Poignet, A. Lindenbaum, and N.K. Man Lipid peroxidation abnormalities in hemodialyzed patients Nephron 64 1 1993 106 109 (Pubitemid 23117178)
11. T.A. Ikizler, J.D. Morrow, L.J. Roberts, J.A. Evanson, B. Becker, and R.M. Hakim Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients Clin Nephrol 58 3 2002 190 197 (Pubitemid 34994045)
12. H. Esterbauer, R.J. Schaur, and H. Zollner Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radic Biol Med 11 1 1991 81 128 (Pubitemid 121003917)
13. M. Boaz, Z. Matas, A. Biro, Z. Katzir, M. Green, and M. Fainaru Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis Kidney Int 56 3 1999 1078 1083 (Pubitemid 29411736)
14. B.P. Oberg, E. McMenamin, F.L. Lucas, E. McMonagle, J. Morrow, and T.A. Ikizler Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease Kidney Int 65 3 2004 1009 1016 (Pubitemid 38251077)
15. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1 1976 31 41
16. L.A. Stevens, J. Coresh, C.H. Schmid, H.I. Feldman, M. Froissart, and J. Kusek Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD Am J Kidney Dis 51 3 2008 395 406 (Pubitemid 351273480)
17. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266.
18. M. Temmar, S. Liabeuf, C. Renard, S. Czernichow, N.E. Esper, and I. Shahapuni Pulse wave velocity and vascular calcification at different stages of chronic kidney disease J Hypertens 28 1 2010 163 169
19. Z.A. Massy, and T. Nguyen-Khoa Oxidative stress and chronic renal failure: markers and management J Nephrol 15 4 2002 336 341
20. M. Morena, and M. Martin-Mateo Stress oxydant, hémo- incompatibilité et complications de la dialyse au long cours Nephrologie 23 5 2002 201 208
21. M. Daschner, H. Lenhartz, D. Bötticher, F. Schaefer, M. Wollschläger, and O. Mehls Influence of dialysis on plasma lipid peroxidation products and antioxidant levels Kidney Int 50 4 1996 1268 1272 (Pubitemid 26342818)
22. G. Lonnemann Chronic inflammation in hemodialysis: the role of contaminated dialysate Blood Purif 18 3 2000 214 223 (Pubitemid 30619960)
23. S. Biasioli, R. Schiavon, L. Petrosino, L. Cavallini, G. Cavalcanti, and E. De Fanti Role of cellulosic and noncellulosic membranes in hyperhomocysteinemia and oxidative stress ASAIO J 46 5 2000 625 634
24. D.V. Barreto, F.C. Barreto, S. Liabeuf, M. Temmar, H. Lemke, and C. Tribouilloy Plasma interleukin-6 is independently associated with mortality in both hemodialysis and predialysis patients with chronic kidney disease Kidney Int 77 6 2010 550 556